Table 2.
Characteristics of AYAs (15–24 years old) newly diagnosed with cancer, by provider type (CCR, 1999–2008).
| Total population (%) | Adult (%a) | Pediatric (%a) | Unknown (%a) | P | |
|---|---|---|---|---|---|
| Number | 9,993 | 8,507 (85.1) | 1,242 (12.4) | 244 (2.5) | — |
| Age (median, SD) | 20 ± 2.9 | 21 ± 2.7 | 16 ± 1.7 | 20.6 ± 2.5 | <0.01 |
| Sex | |||||
| Male | 6,205 (62.1) | 5,277 (62.0) | 755 (60.8) | 173 (70.9) | 0.40 |
| Female | 3,788 (37.9) | 3,230 (38.0) | 487 (39.2) | 71 (29.1) | |
| Race/ethnicity | |||||
| Non-Hispanic white | 4,223 (42.3) | 3,624 (42.6) | 471 (37.9) | 128 (52.4) | <0.01 |
| Non-Hispanic black | 595 (5.9) | 497 (5.8) | 77 (6.2) | 21 (8.6) | |
| Hispanic | 4,002 (40.0) | 3,400 (40.0) | 541 (43.6) | 61 (25) | |
| Asian/Pacific | 995 (10.0) | 828 (9.7) | 140 (11.3) | 27 (11.1) | |
| Other | 178 (1.8) | 158 (1.9) | 13 (1.0) | 7 (2.9) | |
| Socioeconomic status | |||||
| 1 (lowest) | 2,227 (22.3) | 1,887 (22.2) | 303 (24.4) | 37 (15.2) | 0.05 |
| 2 | 2,075 (20.8) | 1,762 (20.7) | 270 (21.7) | 43 (17.6) | |
| 3 | 2,081 (20.8) | 1,775 (20.9) | 227 (18.3) | 79 (32.4) | |
| 4 | 1,878 (18.8) | 1,616 (19.0) | 213 (17.2) | 49 (20.1) | |
| 5 (highest) | 1,732 (17.3) | 1,467 (17.2) | 229 (18.4) | 36 (14.7) | |
| Stageb | |||||
| Metastatic | 2,431 (27.7) | 2,056 (26.9) | 324 (34.8) | 51 (23.3) | <0.01 |
| Nonmetastatic | 5,961 (67.8) | 5,215 (68.3) | 586 (62.9) | 159 (73.0) | |
| Unknown | 395 (4.5) | 365 (4.8) | 22 (2.4) | 8 (3.7) | |
| Cancer diagnosisc | |||||
| Lymphoma | 2,633 (26.4) | 2,302 (27.1) | 278 (22.4) | 53 (21.7) | <0.01 |
| Extracranial GCT | 2,111 (21.1) | 1,969 (23.2) | 87 (7.0) | 55 (22.5) | <0.01 |
| Sarcoma | 1,388 (13.9) | 1,098 (12.9) | 257 (20.7) | 33 (13.5) | <0.01 |
| Acute leukemia | 1,206 (12.1) | 870 (10.2) | 310 (25.0) | 26 (10.7) | <0.01 |
| CNS malignancy | 1,082 (10.8) | 867 (10.2) | 180 (14.5) | 35 (14.3) | <0.01 |
| Carcinoma | 1,022 (10.2) | 946 (11.1) | 47 (3.8) | 29 (11.9) | <0.01 |
| Other | 551 (5.5) | 455 (5.3) | 83 (6.7) | 13 (5.3) | 0.05 |
aPercentages represent distributions within provider subspecialty for all characteristics except total cohort number.
bSolid tumors only.
cSee Table 1 for specific cancers.